U.S. District Judge Denise L. Cote wrote that the one-time "Pharma Bro" violated state and federal laws in exerting monopoly power over Daraprim, which is used to treat parasitic infections and HIV. (Photo: Diego M. Radzinschi/ALM)

Martin Shkreli — who earned the nickname "pharma bro" after his pharmaceutical company dramatically increased the price of an older drug, was sentenced to seven years in prison for securities fraud in 2017 and banned from the pharmaceutical industry for life — has been busy since his release from jail last year. He has developed a virtual health care assistant.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.